Editor's Pick

Amnesty International says Biden must halt arms transfers to Israel

A new assessment from Amnesty International asserts that Israel has used U.S.-supplied weapons against Palestinian civilians in alleged violations of international law, a finding certain to inflame the heated debate about whether the United States should curtail support to its closest Middle Eastern ally.

The advocacy group’s findings, following similar conclusions from an independent panel of experts and recent analysis from other civil society groups, were set to be disclosed later Monday as the Biden administration, under mounting scrutiny, faces a looming deadline for determining whether Israel has abided by the laws of war.

This post appeared first on The Washington Post

You May Also Like

Stock

In this edition of StockCharts TV‘s The Final Bar, Dave shows how breadth conditions have evolved so far in August, highlights the renewed strength in the...

Stock

Major equity indexes rose on Friday after a selloff that hit the Technology sector especially hard. But this doesn’t necessarily mean that everything is...

Latest News

President Joe Biden travels to Triangle, Virginia, Monday to mark Earth Day, where he’ll unveil $7 billion in grant funding for solar power under...

Latest News

Britain’s Prince and Princess of Wales have released a new photo of Prince Louis to mark his sixth birthday on Tuesday, the first image...

Disclaimer: Dealwithbiz.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Dealwithbiz.com